Development of microRNA therapeutics is coming of age
Authors:
Open Access
- 16 June 2014
- journal article
- review article
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 6 (7) , 851-864
Abstract
MicroRNAs (miRNAs) play key regulatory roles in diverse biological processes and are frequently dysregulated in human diseases. Thus, miRNAs have emerged as a class of promising targets for therapeutic intervention. Here, we describe the current strategies for therapeutic modulation of miRNAs and provide an update on the development of miRNA‐based therapeutics for the treatment of cancer, cardiovascular disease and hepatitis C virus (HCV) infection.Keywords
This publication has 122 references indexed in Scilit:
- A Cardiac MicroRNA Governs Systemic Energy Homeostasis by Regulation of MED13Cell, 2012
- MicroRNAs in Stress Signaling and Human DiseaseCell, 2012
- MicroRNA therapeutics in cardiovascular medicineEMBO Molecular Medicine, 2011
- Silencing of microRNA‐21 in vivo ameliorates autoimmune splenomegaly in lupus miceEMBO Molecular Medicine, 2011
- Expanding the MicroRNA Targeting Code: Functional Sites with Centered PairingMolecular Cell, 2010
- A Family of microRNAs Encoded by Myosin Genes Governs Myosin Expression and Muscle PerformanceDevelopmental Cell, 2009
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer ModelCell, 2009
- Origins and Mechanisms of miRNAs and siRNAsCell, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Viral and Cellular MicroRNAs as Determinants of Viral Pathogenesis and ImmunityCell Host & Microbe, 2008